Back to search
Communicating Hydrocephalus
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Communicating Hydrocephalus trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Communicating Hydrocephalus trials you may qualify forTarget population: patients 18 years of age or older who require surgical treatment with lumboperitoneal shunt surgery for traffic hydrocephalus Estimated sampl…
This prospective, multicenter, open-label clinical trial is designed to evaluate the safety and efficacy of rapamycin in the treatment of communicating hydrocep…
The eShunt™ System is a minimally invasive method of treating communicating hydrocephalus. The eShunt System includes a proprietary eShunt Delivery System and t…
The purpose of this study will be to evaluate a novel, minimally invasive method of treating hydrocephalus in adults. The eShunt® System includes a proprietary…
It is known that 33-50% of Classic and Hypermobile Ehlers-Danlos Syndrome patients eventually develop dysautonomia, otherwise known as "POTS" (Postural Orthosta…